Nobuyuki Katakami
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 94
- Lung Cancer Diagnosis and Treatment 30
- Gastric Cancer Management and Outcomes 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Oncology 86
- Lung Cancer Research Studies 42
- Colorectal Cancer Treatments and Studies 17
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Akito Hata (66 shared papers)Keisuke Tomii (35 shared papers)Shiro Fujita (37 shared papers)Reiko Kaji (32 shared papers)Shunichi Negoro (24 shared papers)Koji Takeda (14 shared papers)Masahiro Fukuoka (15 shared papers)Kazuhiko Nakagawa (22 shared papers)
- Journals
- Journal of Thoracic Oncology (23 papers)Annals of Oncology (19 papers)Lung Cancer (15 papers)Journal of Clinical Oncology (10 papers)Cancer Science (7 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Nobuyuki Katakami
195 papers receiving 13.5k citations
Nobuyuki Katakami's Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 8.2k
- Oncology 6.3k
- Cancer Research 1.2k
- Gastroenterology 181
- Molecular Biology 1.9k
Countries citing papers authored by Nobuyuki Katakami
This map shows the geographic impact of Nobuyuki Katakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Katakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Katakami more than expected).
Fields of papers citing papers by Nobuyuki Katakami
This network shows the impact of papers produced by Nobuyuki Katakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Katakami. The network helps show where Nobuyuki Katakami may publish in the future.
Co-authors
The 25 scholars most cited alongside Nobuyuki Katakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Hit paper breakdown → | 2009 | 3562 |
| 2 | Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2019 | 2691 |
| 3 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Hit paper breakdown → | 2018 | 496 |
| 4 | CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3) Hit paper breakdown → | 2018 | 422 |
| 5 | 2006 | 302 | |
| 6 | 2013 | 288 | |
| 7 | 2010 | 244 | |
| 8 | 2004 | 201 | |
| 9 | 2017 | 189 | |
| 10 | 2008 | 177 | |
| 11 | 2013 | 166 | |
| 12 | 2008 | 144 | |
| 13 | 2009 | 141 | |
| 14 | 2021 | 135 | |
| 15 | 2016 | 130 | |
| 16 | 2003 | 126 | |
| 17 | 2016 | 119 | |
| 18 | 2016 | 116 | |
| 19 | 2017 | 113 | |
| 20 | 2011 | 112 |
About Nobuyuki Katakami
Nobuyuki Katakami is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Gastroenterology and Physiology, having authored 201 papers that have together received 13.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (94 papers), Lung Cancer Research Studies (42 papers), Lung Cancer Diagnosis and Treatment (30 papers), Colorectal Cancer Treatments and Studies (17 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer therapeutics and mechanisms (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.2k citations), Oncology (6.3k citations), Cancer Research (1.2k citations), Gastroenterology (181 citations) and Molecular Biology (1.9k citations). Nobuyuki Katakami has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Akito Hata, Keisuke Tomii, Shiro Fujita, Reiko Kaji, Shunichi Negoro, Koji Takeda, Masahiro Fukuoka, Kazuhiko Nakagawa, Toyoaki Hida and Nobuyuki Yamamoto. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer, Journal of Clinical Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.